Two-dose therapy for S. aureus bloodstream infections on par with standard treatment
A National Institutes of Health (NIH)-supported clinical trial has found that the outcome of treating complicated Staphylococcus aureus bloodstream infections with two intravenous (IV) doses of the antibiotic dalbavancin ...
Aug 13, 2025
0
21









